Common use of No Duplication Clause in Contracts

No Duplication. In the event that Executive is eligible for the severance payments and benefits under Section 3 below, Executive shall not be eligible for and shall not receive any of the severance payments and benefits as provided in this Section 2.

Appears in 8 contracts

Sources: Severance and Change of Control Agreement (Synta Pharmaceuticals Corp), Severance and Change of Control Agreement (Synta Pharmaceuticals Corp), Severance and Change of Control Agreement (Synta Pharmaceuticals Corp)

No Duplication. In the event that Executive is eligible for the severance payments and benefits under Section 3 below2 above, Executive shall not be eligible for and shall not receive any of the severance payments and benefits as provided in this Section 23.

Appears in 8 contracts

Sources: Severance and Change of Control Agreement (Synta Pharmaceuticals Corp), Severance and Change of Control Agreement (Synta Pharmaceuticals Corp), Severance and Change of Control Agreement (Synta Pharmaceuticals Corp)

No Duplication. In the event that Executive is eligible for the severance payments and benefits under Section 3 below, Executive shall not be eligible for and shall not receive any of the severance payments and benefits as provided in this Section 2. 3.

Appears in 4 contracts

Sources: Severance and Change of Control Agreement (Madrigal Pharmaceuticals, Inc.), Severance and Change of Control Agreement (Madrigal Pharmaceuticals, Inc.), Severance and Change of Control Agreement (Madrigal Pharmaceuticals, Inc.)

No Duplication. In the event that Executive is eligible for the severance payments and benefits under Section 3 below2 above, Executive shall not be eligible for and shall not receive any of the severance payments and benefits as provided in this Section 23. 4.

Appears in 4 contracts

Sources: Severance and Change of Control Agreement (Madrigal Pharmaceuticals, Inc.), Severance and Change of Control Agreement (Madrigal Pharmaceuticals, Inc.), Severance and Change of Control Agreement (Madrigal Pharmaceuticals, Inc.)